Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-4-8
|
pubmed:abstractText |
Type I diabetes occurs as a result of T-cell-mediated beta-cell destruction. Several candidate antigens have been described recently, including glutamic acid decarboxylase, heat shock protein 65 and peripherin. Restricted T-cell receptor V beta gene usage in non-obese diabetic mice has been suggested but not yet proven. In addition to major histocompatibility genes, several non-H-2 predisposing genes have been mapped on chromosomes 1, 3 and 11.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0952-7915
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
902-5
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:1793533-Autoantigens,
pubmed-meshheading:1793533-Diabetes Mellitus, Type 1,
pubmed-meshheading:1793533-Humans,
pubmed-meshheading:1793533-Immune Tolerance,
pubmed-meshheading:1793533-Immunotherapy,
pubmed-meshheading:1793533-Major Histocompatibility Complex,
pubmed-meshheading:1793533-T-Lymphocytes
|
pubmed:year |
1991
|
pubmed:articleTitle |
Insulin-dependent diabetes mellitus.
|
pubmed:affiliation |
Hôpital Neckar, Paris, France.
|
pubmed:publicationType |
Journal Article,
Review
|